NCT04742257View on ClinicalTrials.gov

Study Evaluating MyoRegulator® Treatment in Post-Stroke Upper Limb Spasticity

NATerminatedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

March 4, 2022

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Muscle SpasticityStroke
Interventions
DEVICE

MyoRegulator® device

Trans-spinal DCS paired with peripheral DCS

Trial Locations (2)

02138

Spaulding Rehabilitation Hospital, Cambridge

02114

Spaulding Rehabilitation Hospital, Charlestown

Sponsors
All Listed Sponsors
collaborator

Spaulding Rehabilitation Hospital

OTHER

collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

PathMaker Neurosystems Inc.

INDUSTRY

NCT04742257 - Study Evaluating MyoRegulator® Treatment in Post-Stroke Upper Limb Spasticity | Biotech Hunter | Biotech Hunter